Impact of lateral parotidectomy for benign tumors on quality of life

Acta Oto-Laryngologica

Volumn 126, Issue 10, 2006, Pages 1091-1095

  Beutner, Dirk ^a   Wittekindt, Claus ^a   Dinh, Stephen ^a   Huttenbrink, Karl Bernd ^a   Guntinas Lichius, Orlando ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Benign parotid gland disease; Lateral parotidectomy; Quality of life

Indexed keywords

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BENIGN TUMOR; CLINICAL ARTICLE; EXPERIENCE; FEMALE; HEAD AND NECK TUMOR; HIGH RISK PATIENT; HUMAN; MALE; OUTCOMES RESEARCH; PAROTID GLAND TUMOR; PAROTIDECTOMY; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SALIVARY GLAND TUMOR;

ADENOLYMPHOMA; ADENOMA; ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROTID GLAND; PAROTID NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33747717479     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600606731     Document Type: Article

References (25)

1. Bradley PJ. Pleomorphic salivary adenoma of the parotid gland: which operation to perform? Curr Opin Otolaryngol Head Neck Surg 2004;12:69-70.
2. Stennert E, Guntinas-Lichius O, Klussmann JP, Arnold G. Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases. Laryngoscope 2001;111:2195-200.
3. O'Brien CJ. Current management of benign parotid tumors - the role of limited superficial parotidectomy. Head Neck 2003;25:946-52.
4. McGurk M, Thomas BL, Renehan AG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer 2003;89:1610-3.
5. Guntinas-Lichius O, Klussmann JP, Schroeder U, Quante G, Jungehuelsing M, Stennert E. Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function. Laryngoscope 2004;114:949-56.
6. Marshall AH, Quraishi SM, Bradley PJ. Patients' perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. J Laryngol Otol 2003;117:624-9.
7. Wiegand DA, Fickel V. Acoustic neuroma - the patient's perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope 1989;99:179-87.
8. Kelleher MO, Fernandes MF, Sim DW, O'Sullivan MG. Health-related quality of life in patients with skull base tumours. Br J Neurosurg 2002;16:16-20.
9. Kwok HC, Morton RP, Chaplin JM, McIvor NP, Sillars HA. Quality of life after parotid and temporal bone surgery for cancer. Laryngoscope 2002;112:820-33.
10. Nikolopoulos TP, Johnson I, O'Donoghue GM. Quality of life after acoustic neuroma surgery. Laryngoscope 1998;108:1382-5.
11. Nagel H, Hotze HJ, Laskawi R, Chilla R, Droese M. Cytologic diagnosis of adenoid cystic carcinoma of salivary glands. Diagn Cytopathol 1999;20:358-66.
12. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
13. Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 1992;31:311-21.
14. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999;17:1008-19.
15. Faber CE, Pedersen AT. Pain and sensory impairment following parotidectomy. A descriptive study. Ugeskr Laeger 1996;158:270-3 (in Danish).
16. Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, Menard M, Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 1994;104:1487-94.
17. Kuttner C, Troger M, Dempf R, Eckardt A. Effectiveness of botulinum toxin A in the treatment of gustatory sweating. Nervenarzt 2001;72:787-90 (in German).
18. Gliklich RE, Goldsmith TA, Funk GF. Are head and neck specific quality of life measures necessary? Head Neck 1997;19:474-80.
19. Sherman AC, Simonton S, Adams DC, Vural E, Owens B, Hanna E. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 2000;126:459-67.
20. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
21. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-51.
22. Nitzan D, Kronenberg J, Horowitz Z, Wolf M, Bedrin L, Chaushu G, et al. Quality of life following parotidectomy for malignant and benign disease. Plast Reconstr Surg 2004;114:1060-7.
23. Chaushu G, Dori S, Sela BA, Taicher S, Kronenberg J, Talmi YP. Salivary flow dynamics after parotid surgery: a preliminary report. Otolaryngol Head Neck Surg 2001;124:270-3.
24. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996;5:555-67.
25. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-92.